Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 170NIH 45NETWORK 8INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Lymphoma 32Lymphoma, Non-Hodgkin 25Lymphoma, B-Cell 15Lymphoma, Follicular 13Recurrence 11Lymphoma, Large B-Cell, Diffuse 11Hodgkin Disease 11Leukemia 10Multiple Myeloma 9Burkitt Lymphoma 8Leukemia, Myeloid, Acute 5Neoplasms 4Lymphoma, T-Cell, Peripheral 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Prostatic Neoplasms 2Obesity 2Neoplasm, Residual 2Mycosis Fungoides 2Lymphoma, B-Cell, Marginal Zone 2Intraocular Lymphoma 2HIV Infections 2Febrile Neutropenia 2Colonic Neoplasms 2Breast Neoplasms 2

Interventions

zanubrutinib 1Vincristine 1Rituximab 1Prednisone 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Congenital Abnormalities × Lymphoid × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡